An Open-Label, Non-Randomized Study To Evaluate The Steady-State Pharmacokinetics Of Sirolimus Tablets In Chinese Patients With Stable Renal Allografts.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2014
At a glance
- Drugs Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Pfizer
- 29 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Nov 2010 New trial record